HK1216503A1 - 用於經皮傳遞安非他命的組合物及方法 - Google Patents

用於經皮傳遞安非他命的組合物及方法

Info

Publication number
HK1216503A1
HK1216503A1 HK16104468.7A HK16104468A HK1216503A1 HK 1216503 A1 HK1216503 A1 HK 1216503A1 HK 16104468 A HK16104468 A HK 16104468A HK 1216503 A1 HK1216503 A1 HK 1216503A1
Authority
HK
Hong Kong
Prior art keywords
amphetamine
compositions
methods
transdermal delivery
transdermal
Prior art date
Application number
HK16104468.7A
Other languages
English (en)
Inventor
蘭伯特 羅伯特
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of HK1216503A1 publication Critical patent/HK1216503A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16104468.7A 2012-10-25 2016-04-19 用於經皮傳遞安非他命的組合物及方法 HK1216503A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718537P 2012-10-25 2012-10-25
US201361791018P 2013-03-15 2013-03-15
PCT/US2013/066523 WO2014066585A1 (en) 2012-10-25 2013-10-24 Compositions and methods for transdermal delivery of amphetamine

Publications (1)

Publication Number Publication Date
HK1216503A1 true HK1216503A1 (zh) 2016-11-18

Family

ID=49546636

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16104468.7A HK1216503A1 (zh) 2012-10-25 2016-04-19 用於經皮傳遞安非他命的組合物及方法

Country Status (9)

Country Link
US (5) US9474722B2 (zh)
EP (1) EP2934496B1 (zh)
JP (1) JP2015535253A (zh)
AR (1) AR093118A1 (zh)
CA (1) CA2889452C (zh)
ES (1) ES2621915T3 (zh)
HK (1) HK1216503A1 (zh)
TW (1) TWI632923B (zh)
WO (1) WO2014066585A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI632923B (zh) 2012-10-25 2018-08-21 諾芬藥品公司 用於經皮傳遞安非他命（ａｍｐｈｅｔａｍｉｎｅ）之組合物及方法
ES2864327T3 (es) 2012-12-28 2021-10-13 Noven Pharma Composiciones de múltiples polímeros para la administración transdérmica de fármacos
JP2016505006A (ja) 2012-12-28 2016-02-18 ノーヴェン ファーマシューティカルズ インコーポレイテッド レボノルゲストレル及びエチニルエストラジオール用の経皮薬物送達システム
WO2014159582A1 (en) 2013-03-14 2014-10-02 Noven Pharmaceuticals, Inc Amphetamine transdermal compositions with acrylic block copolymer
AR095259A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
AR095260A1 (es) * 2013-03-15 2015-09-30 Noven Pharma Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
EP3086783B1 (en) * 2013-12-23 2018-08-29 Noven Pharmaceuticals, INC. Compositions and methods for transdermal delivery of amphetamine
TWI682790B (zh) 2014-07-31 2020-01-21 美商諾芬藥品公司 用於經皮藥物遞送組合物之含聚矽氧之丙烯酸聚合物
EP3532037A4 (en) * 2016-10-31 2020-10-21 The Corporation Of Mercer University TRANSDERMAL ADMINISTRATION OF PHENETHYLAMINE MONOAMINE RELEASERS
AR124577A1 (es) 2021-01-07 2023-04-12 Noven Pharma Composiciones transdérmicas de anfetamina con bajos niveles de carbamato
AR124578A1 (es) 2021-01-07 2023-04-12 Noven Pharma Compuestos de carbamato de anfetamina y métodos relacionados

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994278A (en) 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Breathable backing
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
EP1169025B1 (en) 1999-04-01 2005-08-24 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
EP1420768A2 (en) * 2000-11-01 2004-05-26 Sention, Inc. Methods and compositions for regulating memory consolidation
US20060078640A1 (en) * 2002-12-10 2006-04-13 Hajime Okutsu Belt type continuous plate manufacturing apparatus and method of manufacturing sheet polymer
CN100457064C (zh) 2003-10-28 2009-02-04 诺芬药品公司 透皮递药装置
WO2006041907A2 (en) * 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Transdermal delivery of estradiol
ES2596809T3 (es) 2004-10-08 2017-01-12 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo
US20090221552A1 (en) * 2006-02-28 2009-09-03 The Mclean Hospital Corporation Methods for the Treatment of ADHD and Related Disorders
US20080220054A1 (en) * 2006-10-13 2008-09-11 Shastri V Prasad Modulation of drug release rate from electrospun fibers
JP2008104547A (ja) 2006-10-24 2008-05-08 Aruze Corp 遊技機及び遊技システム
EP2485719A4 (en) 2009-10-07 2013-03-27 Venkata Surya Jagannath Yedida TRANSDERMAL THERAPEUTIC SYSTEM
US20130015092A1 (en) * 2011-07-14 2013-01-17 Nitto Denko Corporation Patch package
US20150104495A1 (en) 2012-10-25 2015-04-16 Noven Pharmaceuticals, Inc. Compositions and methods for transdermal delivery of amphetamine
TWI632923B (zh) 2012-10-25 2018-08-21 諾芬藥品公司 用於經皮傳遞安非他命（ａｍｐｈｅｔａｍｉｎｅ）之組合物及方法
WO2014159582A1 (en) 2013-03-14 2014-10-02 Noven Pharmaceuticals, Inc Amphetamine transdermal compositions with acrylic block copolymer
AR095259A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria

Also Published As

Publication number Publication date
US20170181980A1 (en) 2017-06-29
US9474722B2 (en) 2016-10-25
US20140121611A1 (en) 2014-05-01
US20170246126A1 (en) 2017-08-31
US9456993B2 (en) 2016-10-04
US9901552B2 (en) 2018-02-27
EP2934496B1 (en) 2017-03-15
CA2889452C (en) 2016-09-13
WO2014066585A1 (en) 2014-05-01
ES2621915T3 (es) 2017-07-05
US20180243242A1 (en) 2018-08-30
US10004696B2 (en) 2018-06-26
AR093118A1 (es) 2015-05-20
EP2934496A1 (en) 2015-10-28
CA2889452A1 (en) 2014-05-01
US20150119828A1 (en) 2015-04-30
JP2015535253A (ja) 2015-12-10
TW201427723A (zh) 2014-07-16
TWI632923B (zh) 2018-08-21

Similar Documents

Publication Publication Date Title
HRP20181448T1 (hr) Antihelmintski spojevi i sastavi te postupak za njihovu uporabu
HK1216503A1 (zh) 用於經皮傳遞安非他命的組合物及方法
IL252566B (en) Pharmacy preparations and methods
HK1213798A1 (zh) 治療性化合物和組合物
HK1203367A1 (zh) 醫用有機凝膠方法和組合物
EP2675471A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
HK1206264A1 (zh) 犬尿氨酸- -單加氧酶抑制劑、其藥物組合物及其使用方法
EP2884984A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
EP2917314A4 (en) OLIGOMERATZUSAMMENSETZUNG
HK1203815A1 (zh) 藥物組合物和其製備方法
HK1216610A1 (zh) 用於經皮傳遞非類固醇消炎劑的組合物及方法
EP2897639A4 (en) IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE
EP2806894A4 (en) METHODS AND COMPOSITIONS FOR THERAPEUTICS
EP2632463A4 (en) ARIPIPRAZOL COMPOSITIONS AND METHODS OF THEIR TRANSDERMAL ADMINISTRATION
EP2906041A4 (en) COMPOSITIONS AND METHODS OF USING INAPPETENCE COMPOUND
EP2938391A4 (en) TRANSDERMAL BUPRENORPHINE COMPOSITIONS WITH DELAYED RELEASE AND METHOD OF USE THEREOF
EP2895186A4 (en) THERAPEUTIC COMPOSITIONS AND RELATED METHODS
HK1207558A1 (zh) 丙炔基氨基茚滿透皮組合物
EP2857016A4 (en) INJECTABLE PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN AND TRAMADOL
GB201208315D0 (en) Pharmaceutical methods and compositions
HK1216843A1 (zh) 用於施用奧昔布寧的方法和組合物
HK1212998A1 (zh) 組合物及其使用方法
EP2841164A4 (en) COMPOSITIONS AND USE PROCEDURES FOR THE SKIN
GB201219884D0 (en) New composition and preparation thereof